BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 17, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Feb. 19, 2019
View Archived Issues
FDA establishes new interoperable insulin pump device class – with Tandem up first
Tandem Diabetes Care Inc. saw its shares climb almost 20 percent this week, just as it became the first company to have a product classified in a new FDA category: Alternate Controller Enabled Infusion Pumps (ACE pumps).
Read More
IBM shines at HIMSS with news of collaborations
Read More
Advisory panel says mesh should be superior to repair out to 36 months
Read More
India includes more med tech under existing law as it gears up for new framework
Read More
US, UK ink deal that protects trade regardless of Brexit outcome
Read More
Holiday notice
Read More
Appointments and advancements
Read More
Financings
Read More
Regulatory front
Read More
BioWorld MedTech stock report for public med-tech companies
Read More
Product briefs
Read More
Other news to note
Read More
BioWorld MedTech's Cardiology Extra
Read More
